Sierra Oncology (SRRA) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 31 253 sessions, June 30, 2021 to June 30, 2022
- Largest daily move
- +46.2% close of January 25, 2022
- 1-year change
- +182.4% closing prices, June 30, 2021 to June 30, 2022
- 5-year change
- +17.5% closing prices, June 30, 2017 to June 30, 2022
Company Description
Sierra Oncology (NASDAQ: SRRA) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.3B.
SRRA has gained 182.4% over the past year. The last closing price was $54.99.
This page collects what Stock Titan holds for SRRA, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Sierra Oncology (SRRA) closed at $54.99 on June 30, 2022. Over the past 12 months, the price has gained 182.4%.
SRRA Metrics & Rankings
Price returns through June 30, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Sierra Oncology has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include clinical trial, earnings, management, acquisition, conferences. View all SRRA news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
SRRA Company Profile & Sector Positioning
Sierra Oncology (SRRA) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing SRRA often look at related companies in the same sector, including Syndax Pharmaceuticals, Inc. (SNDX), AbCellera Biologics Inc. (ABCL), Novavax Inc (NVAX), Stoke Therapeutics, Inc. (STOK), and 89bio, Inc. (ETNB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SRRA's relative position within its industry.